BioSpace News Archive

Drug Development

Furiex Pharmaceuticals, Inc. Confirms Takeda Will Present Additional Data From The EXAMINE Trial At American College of Cardiology’s 63rd Annual Scientific Session

March 27, 2014
·
1 min read
Business

TopoTarget A/S Announces Financial Results For The Year Ended Dec 31, 2013

March 27, 2014
·
1 min read
Business

CryoLife, Inc. Acquires Distribution Rights And Purchase Option For Procol® Vascular Bioprosthesis For Hemodialysis Access

March 27, 2014
·
9 min read
Business

Leading Medical Sales And Marketing Executive To Spearhead Akers Biosciences, Inc.’ Commercialization Strategy

March 27, 2014
·
1 min read
Drug Development

Portola Pharmaceuticals, Inc. Initiates Phase 2 Study Of Andexanet Alfa, Potential First-In-Class Factor Xa Inhibitor Reversal Agent, And Factor Xa Inhibitor Edoxaban

March 27, 2014
·
1 min read
Lone Star Bio

ZS Pharma To Present Results Of Phase 2 Trial Of ZS-9 At 2014 American College of Cardiology’s Annual Scientific Session

March 27, 2014
·
1 min read
FDA

Accuray Inc.'s CyberKnife® M6 System Receives Shonin Approval

March 27, 2014
·
4 min read
Genetown

Abiomed’s Impella® Technology Showcased at American College of Cardiology 2014 Scientific Sessions

March 27, 2014
·
1 min read
BioForest

Takeda Pharmaceutical Co. Ltd. Presents Additional Data From The EXAMINE Cardiovascular Safety Outcomes Trial At The American College of Cardiology’s 63rd Annual Scientific Session

March 27, 2014
·
14 min read
Business

NephroGenex Announces Research Collaborations For Pivotal Studies Of Pyridorin™ In Diabetic Nephropathy

March 27, 2014
·
1 min read